73 related articles for article (PubMed ID: 18087070)
1. Validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel enhancers using IonWorks HT.
Jow F; Shen R; Chanda P; Tseng E; Zhang H; Kennedy J; Dunlop J; Bowlby MR
J Biomol Screen; 2007 Dec; 12(8):1059-67. PubMed ID: 18087070
[TBL] [Abstract][Full Text] [Related]
2. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
[TBL] [Abstract][Full Text] [Related]
3. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel openers using QPatch HT.
Zhang XF; Zhang D; Surowy CS; Yao B; Jarvis MF; McGaraughty S; Neelands TR
Assay Drug Dev Technol; 2013 Feb; 11(1):17-24. PubMed ID: 23002961
[TBL] [Abstract][Full Text] [Related]
7. Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.
Harmer AR; Abi-Gerges N; Easter A; Woods A; Lawrence CL; Small BG; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2008; 57(1):30-41. PubMed ID: 17980627
[TBL] [Abstract][Full Text] [Related]
8. Activation of KCNQ2/3 potassium channels by novel pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives.
Jia C; Qi J; Zhang F; Mi Y; Zhang X; Chen X; Liu L; Du X; Zhang H
Pharmacology; 2011; 87(5-6):297-310. PubMed ID: 21577044
[TBL] [Abstract][Full Text] [Related]
9. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
Hadley JK; Noda M; Selyanko AA; Wood IC; Abogadie FC; Brown DA
Br J Pharmacol; 2000 Feb; 129(3):413-5. PubMed ID: 10711337
[TBL] [Abstract][Full Text] [Related]
10. Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels.
John VH; Dale TJ; Hollands EC; Chen MX; Partington L; Downie DL; Meadows HJ; Trezise DJ
J Biomol Screen; 2007 Feb; 12(1):50-60. PubMed ID: 17092914
[TBL] [Abstract][Full Text] [Related]
11. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
Wang K; McIlvain B; Tseng E; Kowal D; Jow F; Shen R; Zhang H; Shan QJ; He L; Chen D; Lu Q; Dunlop J
Assay Drug Dev Technol; 2004 Oct; 2(5):525-34. PubMed ID: 15671650
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
[TBL] [Abstract][Full Text] [Related]
13. Ionworks HT: a new high-throughput electrophysiology measurement platform.
Schroeder K; Neagle B; Trezise DJ; Worley J
J Biomol Screen; 2003 Feb; 8(1):50-64. PubMed ID: 12854998
[TBL] [Abstract][Full Text] [Related]
14. Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques.
Yue JF; Qiao GH; Liu N; Nan FJ; Gao ZB
Acta Pharmacol Sin; 2016 Jan; 37(1):105-10. PubMed ID: 26725738
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions.
Volkers L; Rook MB; Das JH; Verbeek NE; Groenewegen WA; van Kempen MJ; Lindhout D; Koeleman BP
Neurosci Lett; 2009 Oct; 462(1):24-9. PubMed ID: 19559753
[TBL] [Abstract][Full Text] [Related]
16. Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda.
Wilenkin B; Burris KD; Eastwood BJ; Sher E; Williams AC; Priest BT
Assay Drug Dev Technol; 2019 Oct; 17(7):310-321. PubMed ID: 31634018
[No Abstract] [Full Text] [Related]
17. A medium-throughput functional assay of KCNQ2 potassium channels using rubidium efflux and atomic absorption spectrometry.
Scott CW; Wilkins DE; Trivedi S; Crankshaw DJ
Anal Biochem; 2003 Aug; 319(2):251-7. PubMed ID: 12871719
[TBL] [Abstract][Full Text] [Related]
18. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
Maljevic S; Lerche C; Seebohm G; Alekov AK; Busch AE; Lerche H
J Physiol; 2003 Apr; 548(Pt 2):353-60. PubMed ID: 12640002
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay.
Li Q; Rottländer M; Xu M; Christoffersen CT; Frederiksen K; Wang MW; Jensen HS
Anal Biochem; 2011 Nov; 418(1):66-72. PubMed ID: 21782781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
